Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalmer Laboratories is a Cuban pharmaceutical company specializing in the development and production of natural-origin drugs and dietary supplements. As the commercial arm of the National Center for Scientific Research (CNIC) and a member of the BioCubaFarma group, the company is best known for its flagship product, Policosanol (PPG), a cholesterol-lowering agent derived from sugar cane wax. Dalmer also produces Abexol, a mixture of beeswax alcohols used for gastrointestinal protection and antioxidant benefits, and Prevenox for bone health. The company focuses on leveraging Cuba's biodiversity to create evidence-based therapeutic solutions for cardiovascular and metabolic health. Its products are distributed internationally, particularly in Latin America and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalmer Laboratories.